Trademark: 90689781
Word
TRIALMAGNET
Status
Registered
Status Code
700
Status Date
Tuesday, October 10, 2023
Serial Number
90689781
Registration Number
7190229
Registration Date
Tuesday, October 10, 2023
Mark Type
4000
Filing Date
Tuesday, May 4, 2021
Published for Opposition
Tuesday, February 15, 2022

Trademark Owner History
Jeeva Informatics Solutions, Inc. - Original Registrant

Classifications
9 Downloadable software for the processing and analysis of data using artificial intelligence and natural language processing; downloadable software for planning, management and operational management in the field of clinical trials and long-term health management; downloadable software featuring machine learning technology for planning, management, operational management, and study design optimization in the field of clinical trials and long-term health management; downloadable software for estimating the probability of clinical trial success; downloadable software featuring machine learning technology for capturing, collecting, managing, analyzing, and reporting data from clinical trials and drug discovery for use in database management and processing data; downloadable software for real-time and long-term patient monitoring and safety review in the field of clinical trials
35 Business consulting and management in the field of clinical trials, namely, providing information management services; business consulting and management in the field of clinical trials; business consulting and management in the field of regulatory submission management, namely, clinical trial data integrity and immutability; database management in the field of clinical trials; updating and maintenance of data in computer databases in the field of clinical trials; recruitment advertisement services, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs; providing independent review of clinical trials for business purposes; regulatory submission management, namely, assisting others in preparing and filing applications for approval of new drugs and medical devices with governmental regulatory bodies
42 Software as a service (SAAS) services featuring software for the processing and analysis of data using artificial intelligence and natural language processing; Software as a service (SAAS) services featuring software for planning, management and operational management in the field of clinical trials and long-term health management; Software as a service (SAAS) services featuring software featuring machine learning technology for planning, management, operational management, and study design optimization in the field of clinical trials and long-term health management; Software as a service (SAAS) services featuring software for estimating the probability of clinical trial success; Software as a service (SAAS) services featuring software featuring machine learning technology for capturing, collecting, managing, analyzing, and reporting data from clinical trials and drug discovery for use in database management and processing data; scientific consulting services in the field of conducting clinical trials for others; information technology consulting services relating to the collection, review, analysis and reporting of clinical trial, drug development, drug discovery information; providing medical and scientific research information in the field of clinical trials; providing online searchable databases featuring medical and scientific research clinical trial information whereby users can input and collect data and information for research purposes; pharmaceutical research and development information services in the field of health care and clinical trials; Software as a service (SAAS) services featuring software for real-time and long-term patient monitoring and safety review in the field of clinical trials; Software as a service (SAAS) services featuring software for the processing and analysis of data for use in the discovery of disease biomarkers for diagnostic and therapeutic purposes; structural and functional analysis of genomes; database development services, namely, providing configuration and customization of computer databases in the field of medical information related to clinical trials and late phase research; database development services, namely, providing configuration and customization of computer databases in the field of medical information related healthcare and long-term health management; medical research, namely, compiling and analyzing genomics data for use in the discovery of disease biomarkers which are used for diagnostic and therapeutic purposes; conducting clinical trials for others; conducting early evaluations of new pharmaceuticals; conducting research and clinical trials for others relating to medical devices and pharmaceuticals; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; development of pharmaceutical preparations and medicines; laboratory research services relating to pharmaceuticals; medical and scientific research related to designing, organizing, conducting, monitoring, and managing clinical and non-clinical trials and studies on pharmaceuticals and medical devices for others; medical research, namely, collection, organization, analysis, and reporting of medical data in connection with clinical and non-clinical trials and studies on pharmaceuticals and medical devices
TRIAL MAGNET

Trademark Events
Oct 10, 2023
Notice Of Registration Confirmation Emailed
Oct 10, 2023
Registered-Principal Register
Sep 7, 2023
Notice Of Acceptance Of Statement Of Use E-Mailed
Sep 6, 2023
Allowed Principal Register - Sou Accepted
Aug 29, 2023
Teas/Email Correspondence Entered
Aug 29, 2023
Correspondence Received In Law Office
Aug 29, 2023
Assigned To Lie
Apr 17, 2023
Teas Response To Office Action Received
Oct 17, 2022
Notification Of Non-Final Action E-Mailed
Oct 17, 2022
Non-Final Action E-Mailed
Oct 17, 2022
Su - Non-Final Action - Written
Oct 3, 2022
Statement Of Use Processing Complete
Sep 21, 2022
Use Amendment Filed
Oct 3, 2022
Case Assigned To Intent To Use Paralegal
Sep 21, 2022
Teas Statement Of Use Received
Apr 12, 2022
Noa E-Mailed - Sou Required From Applicant
Feb 15, 2022
Official Gazette Publication Confirmation E-Mailed
Feb 15, 2022
Published For Opposition
Jan 26, 2022
Notification Of Notice Of Publication E-Mailed
Jan 7, 2022
Approved For Pub - Principal Register
Jan 7, 2022
Examiner's Amendment Entered
Jan 7, 2022
Notification Of Examiners Amendment E-Mailed
Jan 7, 2022
Examiners Amendment E-Mailed
Jan 7, 2022
Examiners Amendment -Written
Jan 6, 2022
Notification Of Non-Final Action E-Mailed
Jan 6, 2022
Non-Final Action E-Mailed
Jan 6, 2022
Non-Final Action Written
Jan 5, 2022
Assigned To Examiner
Aug 6, 2021
New Application Office Supplied Data Entered
May 7, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24